Richard Hodgson - Concepedia

Author

Richard Hodgson

Also Known As

Hodgson, R., M. Steultjens, R Hodgson, R J Hodgson, R J W Hodgson, R. Hodgson, R. J. HODGSON, R. J. Hodgson, R. J. W. Hodgson, R.J. HODGSON

201

Publications

Citations

H-Index

123

Concepts

All Affiliations

Chapel Allerton Hospital University of Manchester University of Leeds NIHR Leeds Musculoskeletal Biomedical Research Unit Leeds Teaching Hospitals NHS Trust

About

Richard Hodgson is an author at Chapel Allerton Hospital specializing in medicine, engineering, and radiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	28	1.3K
2	Engineering	15	18	681
3	Health Sciences	10	10	406
4	Natural Sciences	8	8	420
5	Public Health	3	3	281

Richard Hodgson

Publications

4.3K

Citations

H-Index

Page 1

	Year	Citations
Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study Chadi Rakieh, J. Nam, Laura Hunt, Annals of the Rheumatic Diseases	2014	230
Single nucleotide polymorphisms in theMATP gene are associated with normal human pigmentation variation Justin Graf, Richard Hodgson, Angela van Daal Human Mutation BiologyPigmentation ProductionAllelic VariantHuman VariationHuman Physical Pigmentation	2005	224
Tendon and ligament imaging Richard Hodgson, Philip O’Connor, Andrew J. Grainger British Journal of Radiology Ligament ImagingSoft Tissue InjuryMedical UltrasoundHealth SciencesMedical Imaging	2012	221
The Discovery of Polo-Like Kinase 4 Inhibitors: Identification of (1<i>R</i>,2<i>S</i>)-2-(3-((<i>E</i>)-4-(((<i>cis</i>)-2,6-Dimethylmorpholino)methyl)styryl)-1<i>H</i>-indazol-6-yl)-5′-methoxyspiro[cyclopropane-1,3′-indolin]-2′-one (CFI-400945) as a Potent, Orally Active Antitumor Agent Peter B. Sampson, Yong Liu, Bryan Forrest, Journal of Medicinal Chemistry	2014	166
Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer Jacqueline M. Mason, Wei Xin, Graham C. Fletcher, Proceedings of the National Academy of Sciences	2017	133
Synthesis of Constrained-Geometry Chiral Di-N-Heterocyclic Carbene Ligands and Their Silver(I) and Palladium(II) Complexes L.G. Bonnet, Richard E. Douthwaite, Richard Hodgson Organometallics Inorganic ChemistryEngineeringHeterocyclicCoordination ComplexTosylmethyl Isocyanide	2003	120
The Discovery of Polo-Like Kinase 4 Inhibitors: Design and Optimization of Spiro[cyclopropane-1,3′[3<i>H</i>]indol]-2′(1′<i>H</i>)-ones as Orally Bioavailable Antitumor Agents Peter B. Sampson, Yong Liu, Narendra Kumar Patel, Journal of Medicinal Chemistry Pharmaceutical SciencePolo-like Kinase FamilyCompound 18Molecular BiologyPharmacotherapy	2014	109
Cobalt nanoparticles as a novel magnetic resonance contrast agent—relaxivities at 1.5 and 3 Tesla Laura M. Parkes, Richard Hodgson, Le Trong Lu, Contrast Media & Molecular Imaging	2008	105
Synovial tissue volume: a treatment target in knee osteoarthritis (OA) Terence W O’Neill, M.J. Parkes, Nasimah Maricar, Annals of the Rheumatic Diseases	2015	101
Protein-Doped Monolithic Silica Columns for Capillary Liquid Chromatography Prepared by the Sol−Gel Method: Applications to Frontal Affinity Chromatography Richard Hodgson, Yang Chen, Zheng Zhang, Analytical Chemistry	2004	95

Page 1